Clinical Trials Logo

Obstructive Jaundice clinical trials

View clinical trials related to Obstructive Jaundice.

Filter by:

NCT ID: NCT01321203 Completed - Clinical trials for Obstructive Jaundice

Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Start date: August 2010
Phase: N/A
Study type: Observational

To assess the safety and efficacy of CO2 insufflations during ERCP 1. Primary objective: To assess the patient's symptoms, abdominal pain and abdominal distension post procedure (ERCP) in the study group. 2. Secondary objective: Endoscopist: - To assess the adequacy of bowel distension for adequate luminal visualization - To assess the peristaltic movement during the ERCP Anesthetist: - To measure the PCO2 level in patient post procedure. - To assess the amount of sedation required during the procedure. - To assess saturation and vital signs through out the procedure. - To assess requirement of buscopan.

NCT ID: NCT01191814 Completed - Pancreatic Cancer Clinical Trials

Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression

Start date: July 2010
Phase: N/A
Study type: Interventional

Covered self expandable metal stents (CSEMS) are three times larger in diameter than 10 Fr plastic stents. When compared to plastic stents, randomized trials have shown longer patency and fewer stent-related complications for CSEMS. The investigators hypothesize that placement of CSEMS would be a better treatment option for preoperative biliary decompression in patients with pancreatic cancer.

NCT ID: NCT00409864 Completed - Gallbladder Cancer Clinical Trials

Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer

Start date: October 2003
Phase: N/A
Study type: Interventional

Cancer of the gallbladder (CaGB) is one of the most common causes of malignant obstructive jaundice. Jaundice is the second most common presentation and occurs in 30-60% of patients with CaGB. It is obstructive in nature and frequently associated with pruritus, which is very disturbing for the patients. The usual mechanism of obstruction is direct infiltration of the bile duct by the tumour. Most patients with CaGB with obstructive jaundice are not amenable to a curative surgical resection and hence effective palliation is the goal of treatment. Although surgical bypass has been the traditional palliative approach, it is associated with substantial morbidity and mortality. Non-operative alternatives in the form of percutaneous and endoscopic drainage are available. A few trials have shown that endoscopic drainage is better than percutaneous drainage in patients with lower end bile duct obstruction due to pancreatic and peri-ampullary cancer. However, the scenario is quite different in patients with upper end of bile duct obstruction as occurs due to CaGB. Endoscopic drainage is associated with a higher incidence of cholangitis in patients with a block at the upper end of the bile duct and the success rate varies from 40% to 80%, while percutaneous drainage may be associated with complications such as biliary leak and bleeding. There has been no randomized trial comparing endoscopic and percutaneous drainage in patients with malignant obstruction due to CaGB. The objective of the present study is to carry out a randomized prospective trial comparing percutaneous and endoscopic biliary drainage in patients with CaGB with obstructive jaundice and to assess their quality of life.